Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/19/2019 |
| Start Date: | July 2008 |
| End Date: | April 2024 |
| Contact: | Morgan Griffith |
| Email: | morgan.griffith@cookmedical.com |
| Phone: | 800-468-1379 |
Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment With the Zenith® Fenestrated AAA Endovascular Graft and the Zenith® p-Branch® and the Effects on Organ and Extremity Perfusion
The Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Single-Center Study is a
clinical trial approved by US FDA to study the safety and effectiveness of the Zenith®
p-Branch® and Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic
aneurysms.
clinical trial approved by US FDA to study the safety and effectiveness of the Zenith®
p-Branch® and Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic
aneurysms.
Inclusion Criteria:
- Abdominal aortic aneurysm > 5.0 cm or 2 times the normal aortic diameter
- Abdominal aortic aneurysm with history of growth > 0.5 cm in 6 months
- Penetrating juxtarenal aortic ulcer > 10 mm in depth and 20 mm in diameter
Exclusion Criteria:
- Age < 18 years
- Life expectancy < 2 years
- Pregnant or breast feeding
- Inability or refusal to give informed consent
- Unwilling or unable to comply with the follow-up schedule
- Additional medical restrictions as specified in the Clinical Investigation Plan
- Additional anatomical restrictions as specified in the Clinical Investigation Plan
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials